These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26168662)

  • 21. Medical Marijuana: Is the Cart Before the Horse?
    D'Souza DC; Ranganathan M
    JAMA; 2015 Jun 23-30; 313(24):2431-2. PubMed ID: 26103026
    [No Abstract]   [Full Text] [Related]  

  • 22. Cannabis: A Neurological Remedy or a Drug of Abuse in India.
    Biswas P; Mishra P; Bose D; Durgbanshi A
    CNS Neurol Disord Drug Targets; 2017; 16(5):576-584. PubMed ID: 28440191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
    Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
    Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. We need to reschedule cannabis. A sane solution to an irrational standoff.
    Bostwick JM
    Minn Med; 2014 Apr; 97(4):36-7. PubMed ID: 24868930
    [No Abstract]   [Full Text] [Related]  

  • 25. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program.
    Greer GR; Grob CS; Halberstadt AL
    J Psychoactive Drugs; 2014; 46(1):73-7. PubMed ID: 24830188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marijuana: The Societal and Health Paradox.
    Betz CL
    J Pediatr Nurs; 2016; 31(4):369-72. PubMed ID: 27181334
    [No Abstract]   [Full Text] [Related]  

  • 27. Medicalising the menace? The symbiotic convergence of medicine and law enforcement in the medicalisation of marijuana in Minnesota.
    Steel RT
    Sociol Health Illn; 2022 Sep; 44(8):1324-1343. PubMed ID: 35939569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Therapeutic Drug Monitoring and Pharmacovigilance to Overcome Some of the Challenges of Developing Medicinal Cannabis from Botanical Origins.
    Dryburgh LM; Martin JH
    Ther Drug Monit; 2020 Feb; 42(1):98-101. PubMed ID: 31479044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical cannabis: Risks related to its indication prior to approval.
    Appiani FJ; Duarte JM
    Arch Argent Pediatr; 2020 Feb; 118(1):64-67. PubMed ID: 31984702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.
    Bonn-Miller MO; Boden MT; Bucossi MM; Babson KA
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):23-30. PubMed ID: 24205805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the public health impacts of legalizing recreational cannabis use in the USA.
    Hall W; Weier M
    Clin Pharmacol Ther; 2015 Jun; 97(6):607-15. PubMed ID: 25777798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
    Belendiuk KA; Baldini LL; Bonn-Miller MO
    Addict Sci Clin Pract; 2015 Apr; 10():10. PubMed ID: 25896576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Doctor's Case for Medical Marijuana.
    American Society of Consultant Pharmacists
    Consult Pharm; 2016 Jul; 31(7):354-5. PubMed ID: 27412310
    [No Abstract]   [Full Text] [Related]  

  • 34. Why Is It Important to Protect Children with Mental Disorders from Medical Cannabis?
    Bou Khalil R
    J Dev Behav Pediatr; 2015; 36(9):766. PubMed ID: 26535885
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cannabis for medical purposes: dynamic surrounding conditions - appropriate information].
    Cremer-Schaeffer P; Knöss W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):799-800. PubMed ID: 31201444
    [No Abstract]   [Full Text] [Related]  

  • 36. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study.
    Lotan I; Treves TA; Roditi Y; Djaldetti R
    Clin Neuropharmacol; 2014; 37(2):41-4. PubMed ID: 24614667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medicinal cannabis].
    Bramness JG
    Tidsskr Nor Laegeforen; 2015 Feb; 135(3):252-3. PubMed ID: 25668545
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
    Eisenberg E; Ogintz M; Almog S
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis for symptom control #279.
    Aggarwal SK; Blinderman CD
    J Palliat Med; 2014 May; 17(5):612-4. PubMed ID: 24749837
    [No Abstract]   [Full Text] [Related]  

  • 40. The cannabis conundrum: steering policy and medicine with insufficient data.
    Vandrey R
    Int Rev Psychiatry; 2018 Jun; 30(3):181-182. PubMed ID: 30179536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.